Risk factors associated with bleeding during and after percutaneous dilational tracheostomy

Martin Beiderlinden; M. Eikermann; N. Lehmann; M. Adamzik; J. Peters

doi:10.1111/j.1365-2044.2007.04979.x

Risk factors associated with bleeding during and after percutaneous dilational tracheostomy

Martin Beiderlinden, M. Eikermann, N. Lehmann, M. Adamzik, J. Peters

Research output: Contribution to journal › Article › peer-review

32 Scopus citations

Abstract

We evaluated the effect of pre-operative coagulation status on the incidence of acute and chronic bleeding in 415 consecutive patients undergoing percutaneous dilational tracheostomy. The incidence of acute bleeding was independent of the coagulation variables tested. The risk of chronic bleeding was higher with an activated partial thromboplastin time above 50 s (OR 3.7 (95% CI 1.1-12.7); NNT 18.4 (95% CI 9.0-∞); p = 0.04), a platelet count below 50 × 10⁹ l^-1 (OR 5.0 (95% CI 1.4-17.2); NNT 12.3 (95% CI 6.2-833.3); p = 0.01) and in the presence of two or more abnormal coagulation variables (OR 9.5 (95% CI 2.3-34.7); NNT 6.2 (95% CI 3.2-68); p = 0.002). Low-dose heparin treatment did not significantly increase the risk of chronic bleeding.

Original language	English (US)
Pages (from-to)	342-346
Number of pages	5
Journal	Anaesthesia
Volume	62
Issue number	4
DOIs	https://doi.org/10.1111/j.1365-2044.2007.04979.x
State	Published - Apr 2007
Externally published	Yes

ASJC Scopus subject areas

Anesthesiology and Pain Medicine

Access to Document

10.1111/j.1365-2044.2007.04979.x

Cite this

@article{6ee4e53a19d94d1eb44503ca309ada4d,

title = "Risk factors associated with bleeding during and after percutaneous dilational tracheostomy",

abstract = "We evaluated the effect of pre-operative coagulation status on the incidence of acute and chronic bleeding in 415 consecutive patients undergoing percutaneous dilational tracheostomy. The incidence of acute bleeding was independent of the coagulation variables tested. The risk of chronic bleeding was higher with an activated partial thromboplastin time above 50 s (OR 3.7 (95% CI 1.1-12.7); NNT 18.4 (95% CI 9.0-∞); p = 0.04), a platelet count below 50 × 109 l-1 (OR 5.0 (95% CI 1.4-17.2); NNT 12.3 (95% CI 6.2-833.3); p = 0.01) and in the presence of two or more abnormal coagulation variables (OR 9.5 (95% CI 2.3-34.7); NNT 6.2 (95% CI 3.2-68); p = 0.002). Low-dose heparin treatment did not significantly increase the risk of chronic bleeding.",

author = "Martin Beiderlinden and M. Eikermann and N. Lehmann and M. Adamzik and J. Peters",

year = "2007",

month = apr,

doi = "10.1111/j.1365-2044.2007.04979.x",

language = "English (US)",

volume = "62",

pages = "342--346",

journal = "Anaesthesia",

issn = "0003-2409",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - Risk factors associated with bleeding during and after percutaneous dilational tracheostomy

AU - Beiderlinden, Martin

AU - Eikermann, M.

AU - Lehmann, N.

AU - Adamzik, M.

AU - Peters, J.

PY - 2007/4

Y1 - 2007/4

N2 - We evaluated the effect of pre-operative coagulation status on the incidence of acute and chronic bleeding in 415 consecutive patients undergoing percutaneous dilational tracheostomy. The incidence of acute bleeding was independent of the coagulation variables tested. The risk of chronic bleeding was higher with an activated partial thromboplastin time above 50 s (OR 3.7 (95% CI 1.1-12.7); NNT 18.4 (95% CI 9.0-∞); p = 0.04), a platelet count below 50 × 109 l-1 (OR 5.0 (95% CI 1.4-17.2); NNT 12.3 (95% CI 6.2-833.3); p = 0.01) and in the presence of two or more abnormal coagulation variables (OR 9.5 (95% CI 2.3-34.7); NNT 6.2 (95% CI 3.2-68); p = 0.002). Low-dose heparin treatment did not significantly increase the risk of chronic bleeding.

AB - We evaluated the effect of pre-operative coagulation status on the incidence of acute and chronic bleeding in 415 consecutive patients undergoing percutaneous dilational tracheostomy. The incidence of acute bleeding was independent of the coagulation variables tested. The risk of chronic bleeding was higher with an activated partial thromboplastin time above 50 s (OR 3.7 (95% CI 1.1-12.7); NNT 18.4 (95% CI 9.0-∞); p = 0.04), a platelet count below 50 × 109 l-1 (OR 5.0 (95% CI 1.4-17.2); NNT 12.3 (95% CI 6.2-833.3); p = 0.01) and in the presence of two or more abnormal coagulation variables (OR 9.5 (95% CI 2.3-34.7); NNT 6.2 (95% CI 3.2-68); p = 0.002). Low-dose heparin treatment did not significantly increase the risk of chronic bleeding.

UR - http://www.scopus.com/inward/record.url?scp=33947668339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947668339&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2044.2007.04979.x

DO - 10.1111/j.1365-2044.2007.04979.x

M3 - Article

C2 - 17381569

AN - SCOPUS:33947668339

SN - 0003-2409

VL - 62

SP - 342

EP - 346

JO - Anaesthesia

JF - Anaesthesia

IS - 4

ER -

Risk factors associated with bleeding during and after percutaneous dilational tracheostomy

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this